Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome

OBJECTIVES: Intravesical Bacillus Calmette-Guérin (BCG) treatment for superficial bladder cancer is interrupted in approximatively 8% of cases as a result of complications. The objective is to report the severe related complications of Bacillus Calmette-Guérin (BCG) following an intravesical instill...

Descripción completa

Detalles Bibliográficos
Autores principales: Waked, R., Choucair, J., Chehata, N., Haddad, E., Saliba, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016447/
https://www.ncbi.nlm.nih.gov/pubmed/32099909
http://dx.doi.org/10.1016/j.jctube.2020.100149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016447/
https://www.ncbi.nlm.nih.gov/pubmed/32099909
http://dx.doi.org/10.1016/j.jctube.2020.100149

Ejemplares similares